GlassScriptPhysician profile
Neha Patel
NPI 1205951126
$35,275.38
in general payments reported to CMS, 2019-2025
8 companies · $4,463 in 2025
The $4,463 reported for 2025 was more than what 79% of Pediatric Hematology-Oncology providers received nationally (typical 2025 total: $207).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,480 · 2022: $9,512 · 2023: $5,750 · 2024: $10K · 2025: $4,463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Honoraria: $3,108 · Food and Beverage: $975 · Travel and Lodging: $391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,810.00 |
| Honoraria | $3,107.50 |
| Food and Beverage | $974.77 |
| Travel and Lodging | $391.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $26,159.38 | 2022-2025 | Koselugo |
| Astrazeneca Pharmaceuticals LP | $5,480.00 | 2021 | |
| Day One Biopharmaceuticals | $3,226.81 | 2025 | Ojemda |
| Springworks Therapeutics, INC. | $228.39 | 2025 | Ogsiveo, Gomekli |
| Foundation Medicine, INC. | $96.14 | 2022 | |
| Siemens Medical Solutions USA, INC. | $66.17 | 2024 | Acuson Origin Diagnostic Ultrasound System |
| Nxstage Medical, INC. | $18.49 | 2025 | Nxstage System One, Pureflow Sl |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neha Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.